SAFETY AND EFFICACY OF TICAGRELOR IN CAROTID ARTERY ANGIOPLASTY IN PATIENTS WITH CLOPIDOGREL RESISTANCE: REAL LIFE EXPERIENCE

Patients receiving carotid artery stent (CAS) are prescribed dual anti-platelet therapy (DAPT) for 3 months. Aspirin and Clopidogrel are the current standard of care. The prevalence of Clopidogrel resistance ranges from 13%-63%. Studies utilising DAPT with Ticagrelor are lacking. We present a first